David M. Grogan DDS, MSD
Dr. David Grogan is currently Associate Professor and Chair in the Department of Oral and Maxillofacial Surgery at Texas A&M University College of Dentistry in Dallas, Texas Dr. Grogan received his Dental Education at Baylor College of Dentistry in Dallas, Texas and his certificate in Oral and Maxillofacial Surgery at Baylor University Medical Center in Dallas, Texas. Dr. Grogan was in private practice in Waco, Texas for 14 years prior to his appointment at Baylor College of Dentistry. Dr. Grogan has many teaching duties in both the undergraduate and graduate curriculum at Baylor College of Dentistry. Dr. Grogan has also been very active in professional organizations locally, regionally and on a national level.  (This speaker has nothing to disclose)

Additional Speakers

Stuart Lieblich, DMD
Dr. Lieblich graduated from Rutgers University and the University of Pennsylvania School of Dental Medicine. He completed his residency in oral and maxillofacial surgery at Kings County/Downstate Medical Center in New York. In 1984 he assumed a full-time position on the faculty of the University of Connecticut until 1988. Currently, he is in private practice in Avon, CT and maintains a part-time teaching appointment at the university as Clinical Professor.  Dr. Lieblich has been a contributor to over 19 textbooks and published over 45 peer reviewed papers and abstracts. He is sought after as a speaker on topics focused on ambulatory anesthesia, dental implants, dentoalveolar surgery and periapical surgery. He has served as President of the American Dental Society of Anesthesiology, and the American Board of Oral and Maxillofacial Surgery. Dr. Lieblich is on the editorial boards of the journals Anesthesia Progress; Oral Surgery, Oral Medicine Oral Pathology (“Triple O”) and the Journal of Oral and Maxillofacial Surgery. Dr. Lieblich serves on many local, state and national committees and currently is a member of the ADA’s Commission on Accreditation and the AAOMS Parameters of Care Committee. (This speaker has disclosed the following: Consultant for Pacira Pharmaceuticals.  Speaker Discloser Resolution: All reported relevant conflicts of interest have been resolved by the organizing committee as of 10/26/18)

William Chung, DDS, MD
Dr. William Chung is an associate professor in the Department of Oral & Maxillofacial Surgery at the University of Pittsburg School of Dental Medicine. He also holds a position of associate professor at the McGowan Institute for Regenerative Medicine. Dr. Chung graduated with a bachelors of arts in English as well as his dental degree from Case Western Reserve University. He subsequently completed his medical degree and certificate in Oral & Maxillofacial Surgery from Temple University. He joined the faculty at the University of Pittsburgh School of Dental Medicine in 2003 upon completion of his training.  Dr. Chung’s clinical interests include all temporomandibular joint (TMJ) related procedures, reconstruction of maxillofacial trauma, treatment of benign maxillofacial pathology, and ambulatory anesthesia. His National Institutes of Health (NIH) supported research project revolves around the replacement of the TMJ cartilage using a xenograft, for which his research team also received the Wallace Coulter Foundation Award in translational research in medicine.  Dr. Chung currently serves on the American Association of Oral & Maxillofacial Surgeons (AAOMS) Committee on Anesthesia (CAN) as well as the Parameters of Care Subcommittee on Trauma. He also is a member of both the American and European Societies of Temporomandibular Joint Surgeons.
(This speaker has nothing to disclose.)

Leonard Tyko, DDS, MD
Leonard Tyko, DDS, MD is a Board Certified Oral & Maxillofacial Surgeon and Fellow of the American College of Surgeons. He is an alumnus of UCLA Dental School (1994), UT Houston School of Medicine (1998),
and UT Houston OMS program. After completing residency in 2000, Dr. Tyko returned to his home state of California, where he joined a longstanding, private practice. He continues this private practice in Santa Rosa today.  In addition to his clinical practice, Dr. Tyko serves as the Chief of Dentistry at Santa Rosa Memorial Hospital, an anesthesia evaluator for the California State Dental Board, and has held multiple, high-level positions in the California Association of Oral and Maxillofacial Surgeons.  During his tenure as President of CALAOMS, Dr. Tyko led the team to oppose a serious, legislative push to limit out-patient, OMS anesthesia delivery. In this capacity, Dr. Tyko met with state stakeholders, legislators, & grieving families to create measured and sensible legislation to protect OMS scope of practice. His efforts led to the defeat of the restrictive bill and set the stage for the passage of legislation that codified the OMS model of out-patient anesthesia delivery in the California Dental Practice Act.  Dr. Tyko is a seasoned lecturer and has presented on numerous topics including team approach to implant surgery, in-office emergency preparation for OMS practices, and regularly leads a local study club.  (This speaker has nothing to disclose.)

Elmer Bernstam, MD
Dr. Elmer Bernstam received Bachelors’ degrees in Biomedical Sciences, Psychology, and Computer Engineering, an MD and a Masters of Science in Engineering, all from the University of Michigan. After an internal medicine residency he matriculated as an NLM Fellow to the Medical Information Sciences program at Stanford and received his Master’s degree in Informatics. He joined the School of Biomedical Informatics at the University of Texas Health Science Center (UTHSC) at Houston as an assistant professor in 2001. Currently, Dr. Bernstam is the Reynolds and Reynolds Professor of Clinical Informatics and Associate Dean for Research at the University of Texas School of Biomedical Informatics at Houston. In addition, he is Professor of Internal Medicine and continues to practice inpatient general internal medicine (hospitalist). Academically, he focuses on clinical and translational research informatics including collecting and “making sense” of large-volume clinical data (clinical data warehousing), consumer informatics and precision oncology decision support. Dr. Bernstam’s group created and maintains the i2b2-based clinical data warehouse with data on approximately 4 million individuals. His group also provides a variety of services to clinical/translational investigators at the University of Texas Health Science
Center at Houston and other institutions. Dr. Bernstam is an elected fellow of the American College of Physicians (2004) and the American College of Medical Informatics (2010). (This speaker has disclosed the following: Stock options/holdings in IBM and Oracle, research grants/contracts with Boehringer Ingelheim and receives honoraria from Roche. Speaker Discloser Resolution: All reported relevant conflicts of interest have been resolved by the organizing committee as of 10/26/18)

Simon Young, DDS, MD, PhD
Dr. Simon Young received his D.D.S. from the University of Toronto.  After graduation, he entered a combined oral & maxillofacial surgery residency / M.D. / Ph.D. program at the University of Texas Health Science Center at Houston and Rice University. Dr. Young then pursued
postdoctoral fellowship training at the Harvard University School of Engineering and Applied Sciences, and was awarded a NIDCR K99/R00
Dentist Scientist Pathway to Independence Award to investigate the use of “immunoengineering” approaches to treat oral cancer.  In 2015, Dr. Young returned to the Department of OMS at UTHealth as an Assistant Professor where his research involves the development and characterization of biomaterials-based platform technologies focused in two areas relevant to oral & maxillofacial surgery: cancer immunotherapy and craniofacial tissue regeneration. With respect to the treatment of oral cancer, his lab has been working on injectable cancer vaccine systems which act as sites for in situ dendritic cell programming. Outside of the biomaterials realm, Dr. Young is also working with collaborators at MD Anderson to develop novel MRI techniques to predict the risk of mandibular osteoradionecrosis following radiation therapy. (This speaker has nothing to disclose.)

Linda Pang, MD
Dr. Linda Pang received her medical degree from Thomas JeffersonUniversity, completed a Clinical Internship in Internal Medicine at Boston University Medical Center, and followed by a fellowship in Geriatrics and Palliative Medicine at Icahn School of Medicine at Mount Sinai. Dr. Pang is the Physician Manager of the Supportive Care Program at Kelsey-Seybold Clinic where she directs the outpatient palliative care
clinic and home based primary care for complex older adults. She is a board certified geriatric, palliative care, and internal medicine physician. Prior to her current position, she practiced geriatrics at MD Anderson Cancer Center where she helped surgeons optimize the care of frail older adults and worked to match the patients’ goals to treatment plans. Her clinical interests include quality improvement in transitions of care, advanced care planning, and population health. (This speaker has nothing to disclose.)

Charles D. Ericsson, MD
Dr. Charles Ericsson, received his medical degree from Harvard Medical School. After residency training at the University of Minnesota hospitals, he completed a fellowship in infectious diseases at UTHealth McGovern
Medical School. Dr. Ericsson is the Dr. and Mrs. Carl V. Vartian Professor of Infectious Diseases and Professor of Medicine at UTHealth McGovern Medical School. He is Head, Clinical Infectious Diseases, Department of Internal Medicine and Director of the Travel Medicine Clinic and the Infectious Diseases Fellowship program. He is board- certified by the American Board of Internal Medicine.  Dr. Ericsson has considerable clinical infectious diseases consultative and teaching experience and duties. In addition, he is chair of multiple committees for Harris County relating to hospital infection control and antibiotic stewardship. He has also received various awards for his teaching. He is Past President of the International Society of Travel Medicine (ISTM) and founding Editor-in-Chief of the Journal of Travel Medicine (and continues as Deputy Editor of the journal and remains a member of the ISTM Publications Committee after having served as its chair). For ISTM, he is currently the chair of the Special Recognitions Committee whose major task is selecting ISTM members for fellowship status. His research interests have included travelers’ diarrhea and travel medicine. He recently was guest editor of a JTM supplement on the Prevention and Treatment of Travelers Diarrhea and senior author on a paper in that supplement that features evidence-based guidelines for the management of travelers’ diarrhea. He is a fellow of the International Society of Travel Medicine and was recently granted fellow status in the Royal College of the Faculty of Travel Medicine (Glasgow). (This speaker has nothing to disclose.)

John Stevenson (Steve) Bynon, Jr., MD, FACS
Dr. Steve Bynon graduated from medical school at the University of Tennessee Center for Health Sciences in 1981. He completed his surgery residency at the University of Alabama Birmingham in 1990 as Chief Resident. Following the completion of his residency in general surgery he trained in abdominal transplantation completing the multi-organ fellowship at the University of Nebraska Omaha under the direction of Byers W. Shaw Jr. in 1993.  Dr. Bynon returned to the University of Alabama in 1993 to initiate their pediatric liver transplant program and in 1994 he was named Director of the liver and pediatric transplant programs. In 2005 he was the first recipient of the Arnold G. Diethelm Chair in Surgery. He was named to “top Doctors” in the USA in 2000. Dr. Bynon moved in July of 2011 to UT Health Medical School in Houston to become director of the Division of  Immunology and Solid Organ Transplantation and is affiliated with Memorial Hermann-Texas Medical Center.  Dr. Bynon serves on advisor boards for BCBSQT and Optum Health Care. He has been active in UNOS on the Liver Intestine subcommittee and Regional Review Boards.  Dr. Bynon has extensive experience in liver transplantation performing over 800 procedures in his career. He has special interest in the surgical management of portal hypertension, benign and malignant tumors of the liver and cholangiocarcinoma. (This speaker has nothing to disclose.)

James Melville, DDS, FACS
Dr. James Melville, is an assistant professor in the Department of Oral and Maxillofacial Surgery, Oral, Head and Neck Oncology and Reconstructive Surgery at The University of Texas Health Science Center at Houston.
He graduated from the University of Michigan School of Dentistry in Ann Arbor, Michigan in 2005 and subsequently completed a General Practice Residency at the University of California San Francisco in 2006.  He joined the faculty as an assistant professor until 2007. He completed a residency in oral and maxillofacial surgery in 2012, followed by a fellowship in oral, head and neck oncology and microvascular reconstructive surgery at the University of Miami/Jackson Memorial Hospital.  Dr. Melville is a diplomate of the American Board of Oral and Maxillofacial Surgery and a fellow of the American Association of Oral and Maxillofacial Surgeons, the American Academy of Craniomaxillofacial Surgeons, and the American College of Surgeons.  He has written a Springer textbook on maxillofacial reconstruction and contributed to six chapters in major textbooks concerning oral and maxillofacial surgery and tissue engineering, and he is the author of more than 15 articles in peer-reviewed journals. He is a reviewer for the Journal of Oral and Maxillofacial Surgery and Triple OOOO journal. He is the chief editor of the Oral & Maxillofacial Surgery/ Dentistry Springer Education video channels.(This speaker has nothing to disclose.)


Russell D. Kan, PhD
Dr. Russell Kane is an award-winning Texas writer/author and wine aficionado with articles, tasting notes and quotes that have appeared in local, regional and national publications over the past 20 years. His
bestselling book, The Wineslinger Chronicles: Texas on the Vine was released by Texas Tech University Press in 2012 and was selected for inclusion into the Grover E. Murray Studies in the American Southwest Collection. His Texas Hill Country Wineries – a wine trail guide and pictorial history of the Texas Hill Country Wineries, was released in 2015 by Arcadia Publications. Dr. Kane who shares his time between Houston and the Texas Hill Country has served as the executive director of the Wine Society of Texas, as a board member of the Texas Wine and Grape Growers Association (TWGGA), and a member of the Texas Department of Agriculture’s Wine Industry Development Advisory Committee.  He is a two-time awardee of the TWGGA Press Award for media coverage of the Texas wine industry. He currently contributes articles for Edible Austin, Edible Houston and Edible Dallas/Ft. Worth, and is a member of the Houston Chronicle tasting panel. His Texas wine selections are featured annually in the Houston Chronicle during October – Texas Wine Month. He blogs at: ww.vintagetexas.com and offers his Texas wine specialist certification class through Houston’s Texas Wine School.
Dr. Kane is a Ph.D. and internationally recognized consultant and awarded scientist. He has over 40 years of experience as an oil and gas industry researcher and business owner with over 300 technical publications to his credit as author or co-author. In 2015, Dr. Kane received his certification as a Texas Master Naturalist. He is a member of the Native Plant Society of Texas where he teaches certification classes in Texas native plant landscaping.

Symposium Course Description and Objectives

This year’s symposium will focus on two areas of importance to the oral and maxillofacial surgery practitioner. An aging population with co-morbid medical conditions, an overweight population posing special challenges and risks, newer pharmacotherapeutics that create a new set of side-effects, and a pediatric population with small physiological reserves; increasing numbers of these types of patients deserve a special review of the “best” practices associated with their management. The second component of the symposium focuses on outpatient anesthesia, with special emphasis on the geriatric, pediatric, and obese patients.

The increasing popularity of extended dental implant and bone grafting cases makes a discussion on strategies for delivering anesthesia for lengthy cases relevant.  Upon completion of this activity, the learner should be able to:

1. Describe the special features of pediatric, geriatric and obese patients related to the delivery and response to outpatient anesthesia
2. Organize and plan responses to specific anesthesia related emergencies in an office setting
3. Review common medical conditions that impact outpatient practice and become familiar with the latest medications and technologies used to treat these patients